Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | C2orf47 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | WRNIP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-07 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | SUCLG1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |